- Home
- CURV vs SIGA Comparison
CURV vs SIGA Comparison
Compare CURV & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CURV | SIGA |
|---|---|---|
| Founded | 2001 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Clothing/Shoe/Accessory Stores | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 226.9M | 223.8M |
| IPO Year | 2021 | 2016 |
Fundamental Metrics
Financial Performance| Metric | CURV | SIGA |
|---|---|---|
| Price | $2.43 | $3.28 |
| Analyst Decision | Hold | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $1.59 | N/A |
| AVG Volume (30 Days) | 398.5K | ★ 612.5K |
| Earning Date | 06-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 13.24% |
| EPS Growth | N/A | ★ N/A |
| EPS | 0.06 | ★ 0.13 |
| Revenue | ★ $1,000,092,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.15 | $224.81 |
| P/E Ratio | $38.67 | ★ $24.31 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.94 | $2.83 |
| 52 Week High | $2.86 | $9.29 |
Technical Indicators
Market Signals| Indicator | CURV | SIGA |
|---|---|---|
| Relative Strength Index (RSI) | 54.85 | 53.78 |
| Support Level | $1.02 | $2.87 |
| Resistance Level | $2.85 | $3.32 |
| Average True Range (ATR) | 0.19 | 0.13 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 32.41 | 70.13 |
Price Performance
Historical ComparisonAbout CURV Torrid Holdings Inc.
Torrid Holdings Inc is a direct-to-consumer brand in North America dedicated to offering a diverse assortment of stylish apparel, intimates, and accessories skillfully designed for curvy women. Its extensive collection features high-quality merchandise, including tops, bottoms, denim, dresses, intimates, activewear, footwear, and accessories. The company has one reportable segment, which includes the operation of its e-Commerce platform and stores.
About SIGA SIGA Technologies Inc.
SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.